Department of Pharmaceutical Chemistry and Pharmacognosy, Center of Excellence for Innovation in Chemistry, Faculty of Pharmaceutical Sciences, Naresuan University, Phitsanulok 65000, Thailand.
Phytochem Anal. 2011 Sep-Oct;22(5):385-91. doi: 10.1002/pca.1293. Epub 2011 Mar 17.
In Ayurvedic medicines, Bacopa monnieri (L.) Wettst. (brahmi) is known as a medicinal plant used for memory enhancement. Its active compounds are classified as pseudojujubogenin and jujubogenin glycosides. Owing to the lack of chromophore in the saponin glycoside structures, HPLC-UV-vis gives low sensitivity for determination of such compounds. In the case of the detection of small amounts of saponin glycosides, immunological assay could be a suitable method.
To develop and validate a sensitive enzyme-linked immunosorbant assay (ELISA) using monoclonal antibody (MAb) against bacoside A₃, the major jujubogenin glycoside found in brahmi.
An immunogen was prepared by conjugating bacoside A₃ with a bovine serum albumin (BSA). To determine its immunogenicity, the ratio of hapten in bacoside A₃-BSA conjugate was determined by matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry (MALDI-TOF-MS). After immunisation in mice, hybridomas secreting MAbs against bacoside A₃ were produced by fusing the immunised splenocytes with SP2/0- Ag14 myeloma cells. The antibody was raised specifically against jujubogenin glycosides. The ELISA using anti-bacoside A₃ MAb was developed.
Bacoside A₃ in the range of 3.05-97.70 ng mL⁻¹ could be detected by ELISA using anti-bacoside A₃ MAb. The assay showed a detection limit of 0.48 ng mL⁻¹ (0.517 nm). The validation study showed that the method was precise, accurate and sensitive. Interestingly, the MAb showed cross-reactivity with the other jujubogenin glycosides, bacopaside X and IV. However, it did not show cross-reactivity with any of pseudojujubogenin glycosides.
The study demonstrated that ELISA using anti-bacoside A₃ MAb can be used for determination of total jujubogenin glycosides in brahmi.
在印度阿育吠陀医学中,印度人参(Bacopa monnieri(L.) Wettst.)被认为是一种用于增强记忆力的药用植物。其活性化合物被归类为伪薯蓣皂苷元和薯蓣皂苷元糖苷。由于皂苷糖苷结构中缺乏生色团,高效液相色谱-紫外可见分光光度法(HPLC-UV-vis)对这些化合物的测定灵敏度较低。在检测少量皂苷糖苷的情况下,免疫测定可能是一种合适的方法。
使用针对 Brahmi 中发现的主要薯蓣皂苷元糖苷巴考苷 A₃的单克隆抗体(MAb)开发和验证一种灵敏的酶联免疫吸附测定(ELISA)。
通过将巴考苷 A₃与牛血清白蛋白(BSA)偶联制备免疫原。通过基质辅助激光解吸/电离飞行时间质谱(MALDI-TOF-MS)测定巴考苷 A₃-BSA 缀合物中半抗原的比例来确定其免疫原性。在小鼠免疫后,通过将免疫脾细胞与 SP2/0-Ag14 骨髓瘤细胞融合来产生分泌针对巴考苷 A₃的 MAb 的杂交瘤。该抗体特异性针对薯蓣皂苷元糖苷。开发了使用抗巴考苷 A₃ MAb 的 ELISA。
使用抗巴考苷 A₃ MAb 的 ELISA 可以检测 3.05-97.70ng/mL 范围内的巴考苷 A₃。该测定法的检测限为 0.48ng/mL(0.517nm)。验证研究表明该方法精确、准确且灵敏。有趣的是,该 MAb 与其他薯蓣皂苷元糖苷,如 bacopaside X 和 IV 表现出交叉反应性,但与任何伪薯蓣皂苷元糖苷均无交叉反应性。
该研究表明,使用抗巴考苷 A₃ MAb 的 ELISA 可用于测定 Brahmi 中的总薯蓣皂苷元糖苷。